Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

ELGX - Endologix Inc.

Previous close
0.22
0   0%

Share volume: 0
Last Updated: Wed 15 Jul 2020 06:00:00 AM CEST
Medical Specialties: 0%

PREVIOUS CLOSE
CHG
CHG%
$0.22
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
23%
Profitability 6%
Dept financing 25%
Liquidity 68%
Performance 28%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$0.22
P/E Ratio 
N/A
DAY RANGE
$0.22 - $0.22
EPS 
-$3.20
52 WEEK RANGE
$0.22 - $7.10
52 WEEK CHANGE
-$96.60
MARKET CAP 
4.218 M
YIELD 
N/A
SHARES OUTSTANDING 
19.172 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$16,648,647
AVERAGE 10 VOLUME 
$12,438,432
AVERAGE 30 VOLUME 
$4,404,490
Company detail
CEO: John Onopchenko
Region: US
Website: http://www.endologix.com
Employees: 488
IPO year: -
Issue type: Common Stock
Market: NASDAQ
Industry: Medical Specialties
Sector: Health Technology

Endologix, Inc. engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA.

Recent news